Finigan Paul M 4/A
4/A · CURAGEN CORP · Filed Oct 6, 2009
Insider Transaction Report
Form 4/AAmended
CURAGEN CORPCRGN
Finigan Paul M
Former EVP & General Counsel
Transactions
- Disposition to Issuer
Common Stock
2009-10-01−75,000→ 0 total
Footnotes (1)
- [F1]Footnote (1) of the original Form 4 is amended and restated in its entirety to read as follows: "Disposed of pursuant to merger agreement between issuer and Celldex Therapeutics, Inc. in exchange for 20,542 shares of Celldex Therapeutics, Inc. common stock."